Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:16 PM
Ignite Modification Date: 2025-12-25 @ 7:50 PM
NCT ID: NCT02155335
Description: The study was crossover using 2 types of injection methods per participant, without a wash-out period between injection types. It was not possible to relate an adverse event (AE) to a specific injection method. Hence, per protocol, AEs were summarized for all participants who received at least 1 dose of golimumab, regardless of injection type.
Frequency Threshold: 5
Time Frame: up to 14 days post injections
Study: NCT02155335
Study Brief: Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
All Treated Participants All participants who received at least 1 injection from either prefilled syringe or Smartject None None 0 99 0 99 View
Serious Events(If Any):
Other Events(If Any):